Neil Garry Arthur
- SEC CIK
- 0001586785
No open-market purchases or sales filed in the past year.
Current role at each company
- CLDX Celldex Therapeutics, Inc.Directoras of Jun 29, 2026
- AVTX Avalo Therapeutics, Inc.Chief Executive Officeras of May 26, 2026
- ZURA Zura Bio LtdDirectoras of May 22, 2023
- ARNA Arena Pharmaceuticals IncDirectoras of Mar 11, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Neil Garry Arthur as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AVTX Avalo Therapeutics, Inc.
Chief Executive Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 (view filing) | Jun 9 | 4 days | Neil Garry ArthurCEO and Chairman of the Board | PPurchase | +4.00K | $3.42 | +$13.7K | +43.4%13.2K after | |
| Dec 12, 2022 (view filing) | Dec 9 | 3 days | Neil Garry ArthurCEO and Chairman of the Board | PPurchase | +2.08K | $4.42 | +$9.21K | +29.2%9.22K after | |
| Dec 14, 2021 (view filing) | Dec 10 | 4 days | Neil Garry ArthurChief Scientific Officer | PPurchase | +4.27K | $1.57 | +$6.70K | +5.2%85.6K after |